[Class : 5] Pharmceutical And Medicinal Preparations And Substances.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical And Medicinal Preparations And Substances.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical And Medicinal Preparations And Substances
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
View +6 more Brands for Inexios Pharmaceuticals Private Limited.
Documents
Form MGT-7-03012020_signed
List of share holders, debenture holders;-30122019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29112019
Directors report as per section 134(3)-29112019
Form AOC-4-01122019_signed
Form ADT-1-18042019_signed
Copy of resolution passed by the company-18042019
Copy of written consent given by auditor-18042019
Form DIR-12-12022019_signed
Declaration by first director-05022019
Form MGT-7-18012019_signed
List of share holders, debenture holders;-02012019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-02012019
Directors report as per section 134(3)-02012019
Form AOC-4-02012019_signed
Form DIR-11-17052018_signed
Acknowledgement received from company-17052018
Notice of resignation filed with the company-17052018
Proof of dispatch-17052018
Declaration by first director-10052018
Evidence of cessation;-10052018
Declaration of the appointee director, Managing director, in Form No. DIR-2;-10052018
Notice of resignation;-10052018
Interest in other entities;-10052018
Form DIR-12-10052018_signed
List of share holders, debenture holders;-21122017
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-21122017